Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19 - Top-Institutions - MDSpire

Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19

  • By

  • Wajeeha Ansari

  • Henriette Coetzer

  • Kelly A Gebo

  • Jinma Ren

  • Amie Scott

  • Joseph C Cappelleri

  • Ashley S Cha-Silva

  • Heidi Leister-Tebbe

  • August 1, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Allergy and Infectious Diseases (NIAID)
    National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Trials
    • Virology

  • #2

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Epidemiology
    • Clinical Research

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Patient Outcomes

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Trials
    • Health Outcomes Research

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Clinical Research
    • Epidemiology

Original Source(s)

Patient-Reported Outcomes of Nirmatrelvir Treatment for High-Risk, Nonhospitalized Adults With Symptomatic COVID-19

  • by Wajeeha Ansari, Henriette Coetzer, Kelly A Gebo, Jinma Ren, Amie Scott, Joseph C Cappelleri, Ashley S Cha-Silva, Heidi Leister-Tebbe

  • August 1, 2025

Related Content

Beyond recovery: long-term cardiovascular risks after severe COVID-19 requiring intensive care

Explainable machine learning-based mortality risk stratification for older adults with COVID-19: pinpointing core immunological biomarkers and revealing dose-threshold effects

Characterization of post-COVID syndrome by self-perceived symptom severity stratified by infection wave: beyond COVID, a prospective, multicenter cohort study in Germany